-

Humanetics Corporation to Participate in Benchmark Healthcare Investor Conference This Week

MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation announced today that executive management team members will participate in the Benchmark Company’s 5th Annual Healthcare House Call Virtual Investor Conference this week.

Humanetics to participate in benchmark investor conferrence.

Share

The conference takes place on Thursday, May 29th, and Humanetics will be featured during the 1:30 – 2:10 ET time slot.

About Humanetics Corporation

Humanetics is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs, with a focus on radiation modulators for oncology and medical countermeasures. For more information, visit www.humaneticscorp.com.

Contacts

Ronald J. Zenk
Chief Executive Officer
Humanetics Corporation
952-400-0400

Industry:

Humanetics Corporation

Release Versions
English

Contacts

Ronald J. Zenk
Chief Executive Officer
Humanetics Corporation
952-400-0400

More News From Humanetics Corporation

Humanetics Corporation to Present at Upcoming Investor Conference

MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company pioneering novel prophylactic Medical Countermeasures for warfighters, first responders, and others at risk of radiation exposure from nuclear incidents, industrial accidents, or cancer radiation therapy, today announced that RADM Colin G. Chinn, MC, USN (Ret), MD, the Company’s Chief Medical Officer, will be presenting at the Big Idea CONNECTpreneur Baltimore Forum on February 05,...

Humanetics Corporation Appoints Timothy E. Morris as Chief Operating Officer

MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation (Humanetics), an advanced clinical-stage specialty pharmaceutical company, is pleased to announce the appointment of Timothy E. Morris as its new Chief Operating Officer (COO). Humanetics is a leading innovator in radiation medical countermeasure development, also pioneering novel approaches to normal tissue protection in oncology-related radiation therapy and mitigating the inflammatory response in pulmonary diseases. In his new capacity at...

Humanetics Corporation to Host a Virtual Panel Focused on Unmet Needs in Radiation Oncology and Pulmonology

MINNEAPOLIS--(BUSINESS WIRE)--HUMANETICS CORPORATION TO HOST A VIRTUAL PANEL FOCUSED ON UNMET NEEDS IN RADIATION ONCOLOGY AND PULMONOLOGY...
Back to Newsroom